Goat Polyclonal MYD88 antibody. Suitable for ICC, Flow Cyt, WB, IHC-P and reacts with Human samples. Cited in 11 publications. Immunogen corresponding to Synthetic Peptide within Human MYD88 aa 250-300.
View Alternative Names
Myeloid differentiation primary response protein MyD88, MYD88
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MyD88 antibody (AB28763)
ab28763 (4µg/ml) staining of paraffin embedded Human Tonsil shows staining of clusters of cells some of which are likely plasma cells. Steamed antigen retrieval with Tris/EDTA buffer pH 9, HRP-staining.
- Flow Cyt
Unknown
Flow Cytometry - Anti-MyD88 antibody (AB28763)
Flow cytometric analysis of paraformaldehyde fixed Jurkat cells (blue line), permeabilized with 0.5% Triton using ab28763 at 10ug/ml followed by Alexa Fluor 488 secondary antibody at 1ug/ml. IgG control : Unimmunized goat IgG (black line) followed by Alexa Fluor 488 secondary antibody.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-MyD88 antibody (AB28763)
Immunofluorescence analysis of paraformaldehyde fixed Jurkat cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml), showing cytoplasmic staining. The nuclear stain is DAPI (blue). Negative control : Unimmunized goat IgG (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml).
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-MyD88 antibody (AB28763)
Immunofluorescence analysis of paraformaldehyde fixed U2OS cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml), showing nuclear and cytoplasmic staining. The nuclear stain is DAPI (blue). Negative control : Unimmunized goat IgG (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml).
- WB
Supplier Data
Western blot - Anti-MyD88 antibody (AB28763)
Lysates in RIPA buffer. Detected by chemiluminescence.
All lanes:
Western blot - Anti-MyD88 antibody (ab28763) at 0.5 µg/mL
All lanes:
Human Spleen lysate at 35 µg
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MyD88 plays a significant role in mediating immune responses by forming part of a complex that includes IRAK kinases and TRAF6. When TLRs or IL-1Rs activate MyD88 this adaptor protein recruits IRAK4 which then phosphorylates IRAK1 or IRAK2. This cascade promotes the activation of NF-κB and MAPK pathways leading to the production of inflammatory cytokines. The MyD88-dependent pathway is integral to innate immunity influencing how the body responds to pathogen infection and inflammation.
Pathways
MyD88 integrates into both the TLR signaling and IL-1R signaling pathways. Key related proteins in these pathways include interleukin-1 receptor-associated kinase (IRAK) and tumor necrosis factor receptor-associated factor 6 (TRAF6). MyD88 initiates the recruitment and activation of IRAK1 and IRAK4 following receptor engagement leading to subsequent activation of downstream signals. As part of these pathways MyD88 mediates cellular responses important for immune system signaling and inflammatory response regulation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Oncology research 33:133-148 PubMed39735680
2024
Applications
Unspecified application
Species
Unspecified reactive species
Gut microbes 16:2313769 PubMed38353638
2024
Applications
Unspecified application
Species
Unspecified reactive species
Gut microbes 14:2091369 PubMed35758253
2022
Applications
Unspecified application
Species
Unspecified reactive species
iScience 25:104561 PubMed35769880
2022
Applications
Unspecified application
Species
Unspecified reactive species
Kidney diseases (Basel, Switzerland) 8:231-245 PubMed35702702
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 13:838261 PubMed35370734
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 23: PubMed35269806
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 12:693298 PubMed34366849
2021
Applications
Unspecified application
Species
Unspecified reactive species
Stem cells international 2020:2134565 PubMed32300366
2020
Applications
Unspecified application
Species
Unspecified reactive species
European journal of oral sciences 118:333-41 PubMed20662905
2010
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com